
    
      To explore the effect of Lenalidomide, dexamethasone and Medi-551 on multiple myeloma cancer
      stem cells (CSCs). Myeloma CSCs will be assessed by a clonogenic assay from the bone marrow
      and flow cytometry from peripheral blood.
    
  